The U.S. Government Accountability Office (GAO), the investigative arm of Congress, often called the congressional watchdog, spoke out against the U.S. Treasury Department’s interim final rule narrowing the Corporate Transparency Act (CTA), warning that the now-gutted law could open the door to fraudulent activity.

In its May 29, 2026 report, the GAO highlighted the “resulting

Private equity investment in law firms is no longer merely theoretical. It is increasingly being pursued through affiliated-entity structures, often described as legal services organizations (LSOs), which are designed to operate within professional responsibility constraints while introducing external capital and operational capabilities to the legal sector.

In an LSO model, the law firm remains owned

A common pathway to growth for small and midsize firms – becoming an acquisition target – is losing its luster. Many firms are not interested in being acquired or relinquishing their identity to a national platform. At the same time, they recognize that remaining competitive requires capital investment that traditional partnership structures may struggle to

Benjamin Malerba and Emily Manning wrote the Law360 article, “How to Prep as Private Equity Starts Investing in Law Firms,” which covers the emerging trend of PE investing in professional services firms.

Here is an excerpt.

Private equity investment in professional services has expanded significantly over the past decade, first gaining traction in healthcare and

Recent New York decisions demonstrate a judicial trend toward enforcing contractual provisions negotiated between sophisticated parties while maintaining limited exceptions for fraud and fiduciary duty claims.

New York courts routinely enforce negotiated contractual provisions, particularly between sophisticated commercial parties, but recognize narrow exceptions in specific factual situations. Courts also continue to reaffirm that fiduciary duties

Stella Lellos and Lindsay Brocki wrote, “M&A Earnouts: The Devil Is in the Uncertainty,” for the Winter 2026 issue of USLAW Magazine.

The article describes the advantages and pitfalls of earnout provisions as well as the transaction types that can most benefit from this mechanism.

Click here to read the article.

It hasn’t taken long for the business world to start unpacking the implications of the newly passed One Big Beautiful Bill Act (OBBBA). While media coverage has mostly centered on its impact on individual taxpayers and the broader economy, the legislation is likely to have meaningful consequences for M&A in particular. While the full effect

Just last week, we reported that the 2025/26 NYS Budget Bill did not include a provision that would have increased the requirements for seeking Department of Health (DOH) approval of a material healthcare transaction (which generally means one that increases revenues from healthcare services by at least $25 million) [here]. We have previously written about

We recently wrote about proposed legislation that would have substantially increased the existing reporting requirements for material healthcare transactions in NYS that have existed since Public Health Law (PHL) Article 45-A was enacted two years ago. We provided a detailed review of the current PHL 45-A here and here.

The proposed legislation would have amended PHL 45-A and

With lowering interest rates and federal deregulation, 2025 promises to be a robust comeback year for health care mergers and acquisitions (M&A). At the same time, we’re likely to see more conservative pricing, especially as private equity investors